Alzheamer's clinical tests based on biomarker panels

20 Things To Know About Alzheimer's Disease

Please Help Support Alzheimer's Research Today! 

Your Alzheimer's donation will help billions live without it.

Improve Your Brain

Alzheimer's facts

DONATE NOW

(  better diagnostic tools for Alzheimer's disease )

A study of 1,000 patients has shown three distinct "biomarkers" in people's blood which can discriminate between mild "cognitive impairment" (a syndrome often preceding Alzheimer's), Alzheimer's itself and control groups who do not have the condition.

Proteome Sciences is filing patents for the "panels" in the blood that contain the biomarkers.

It is estimated that 60% of people with Alzheimer's disease have not been properly diagnosed and therefore are not being given the correct drugs and care. 

The capability to distinguish between different levels of the disease will enable drug developers to improve patient care and people with mild symptoms are likely to benefit the most from new disease-modifying drugs.

The key is that Proteome may be able to develop a simple blood test to determine progression of Alzheimer's as opposed to the current diagnostic methods of invasive lumbar punctures or expensive MRI scans. Continue to read: livecharts.co.uk

Read more here: http://www.bnd.com/2012/02/07/2047945/obama-to-seek-more-alzheimers.html#storylink=cpy

TODAY'S PHOTO

How the Body Processes Vitamin D

Prevention trials for vitamins and supplements are notoriously difficult, but some researchers aren’t giving up on finding proof that vitamin D helps ward off disease. Read more: the-scientist.com

Беларусь ТВ

Posted YVN (AMYLOID @ PHOTO).